Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders. Angiogenesis, i.e. the formation of new blood vessels, is a characteristic feature of many severe pathologies such as cancer, rheumatoid arthritis and age-related macular degeneration.
The company has been a pioneer in the isolation, engineering and clinical development of lead products capable of targeting angiogenesis in-vivo and has been the first in the world to demonstrate that human monoclonal antibodies, specific for a marker of angiogenesis, can efficiently and selectively target the tumor neo-vasculature both in animal models and in cancer patients.
At present, Philogen has four promising anti-cancer antibody derivatives and an antibody derivative for the treatment of rheumatoid arthritis in clinical studies. Two registrational studies are in planning.
Our Zurich-based daughter company Philochem serving as the R&D unit isolates the most promising candidate products, while in Siena (Italy) the pharmaceuticals are produced according to GMP standards and advanced to clinical trials.
Philogen generates revenue from a diversified range of activities, has signed agreements with major pharmaceutical companies and owns a diversified portfolio of international patents.
Location: Italy, Tuscany, Sovicille
Member count: 51-200
Total raised: $69.639603M
Founded date: 1996
Investors 1
Date | Name | Website |
- | NovaCapita... | novacapita... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
13.05.2019 | - | $69.639603... | - | finsmes.co... |
Mentions in press and media 19
Date | Title | Description | Source |
14.08.2023 | Startup Showcase: Philogen – Pioneering Biopharmaceutical In... | In the realm of healthcare, a remarkable startup is leading the way in developing groundbreaking bio... | eustartup.... |
28.03.2023 | Philogen Announces Publication of a New Study in Collaborati... | Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learni... | aithority.... |
08.11.2021 | Philogen to Attend the Festival of Biologics Basel on Novemb... | 2021, Events, Scientific Philogen to Attend the Festival of Biologics Basel on November 10, 2021 N... | marketscre... |
02.11.2021 | Philogen S.p.A. announces its Q3 2021 Results on Thursday 11... | Main Office: Loc. Bellaria, 35 - 53018 Sovicille (SI), Italy e-mail: info@philogen.it- web site: ww... | marketscre... |
06.09.2021 | Philogen S p A : announces its maiden Half Year 2021 Results... | Main Office: Loc. Bellaria, 35 - 53018 Sovicille (SI), Italy e-mail: info@philogen.it- web site: ww... | marketscre... |
02.07.2021 | Philogen S p A : Announces First Quarter 2021 Results | Press Releases Philogen Announces First Quarter 2021 Results May 21, 2021 Philogen Announces Firs... | marketscre... |
02.07.2021 | Philogen Announces R&D Program Update | Philogen Announces R&D Program Update Fibromun shows activity in pretreated glioma and sarcoma ... | marketscre... |
02.07.2021 | Philogen S p A : annuncia i risultati del primo trimestre 20... | Press Releases Philogen annuncia i risultati del primo trimestre 2021 May 12, 2021 Philogen annun... | marketscre... |
02.07.2021 | Philogen S p A : Il Consiglio di Amministrazione approva il ... | Press Releases Il Consiglio di Amministrazione approva il progetto di bilancio di esercizio Apr 27... | marketscre... |
02.07.2021 | Philogen S p A : The Board of Directors approves the draft f... | Press Releases The Board of Directors approves the draft financial statements Apr 27, 2021 The Bo... | marketscre... |
Show more